MAFA
VXRT

MJT & Associates Financial Advisory’s Vaxart VXRT Stock Holding History

MJT & Associates Financial Advisory’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,500
Closed -$678 – 516
2025
Q2 		$678 Hold
1,500
– – ﹤0.01% 438
2025
Q1 		$611 Buy
+1,500
New +$962 ﹤0.01% 446

Other funds holding VXRT

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.27B AUM 19.34% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
CFO
Custos Family Office Austin, Texas $147M AUM 17.83% 1-Year Est. Return
LCM
LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MJT & Associates Financial Advisory's VXRT Position: Q3 2025 in Review

MJT & Associates Financial Advisory sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 1,500 shares — an estimated $678 sold.

MJT & Associates Financial Advisory first reported a position in VXRT in Q1 2025 and held it in 2 quarters. The position peaked at $678 in Q2 2025. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • MJT & Associates Financial Advisory reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • MJT & Associates Financial Advisory sold 1,500 Vaxart shares in Q3 2025, an estimated $678.
  • MJT & Associates Financial Advisory first reported a position in Vaxart in Q1 2025 and held it in 2 quarters.
  • MJT & Associates Financial Advisory's Vaxart position peaked at $678 in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2025, filed 15 Oct 2025.